# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Indivior PLC (OTCPK:INVVY) (LSE:INDV) has completed the acquisition of Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) The transact...
CFIUS clearance represents the final required regulatory approval to complete the proposed merger Completion remains ...
Opiant Pharmaceuticals Inc. (NASDAQ:OPNT) announced today the expiration of the waiting period under the United States (U.S.) H...
- Reuters
Opiant Pharma's (NASDAQ:OPNT) short percent of float has risen 148.0% since its last report. The company recently reported ...
Opiant Pharma's (NASDAQ:OPNT) short percent of float has risen 13.79% since its last report. The company recently reported ...
Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ:OPNT) today announced it has completed submission of its rolling New Drug Appli...
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed ...